SME Times is powered by   
Search News
Just in:   • Tier 2 and 3 Indian cities to emerge as pivotal real estate growth hubs in 2025  • India’s Jaduguda Mines discovery extends uranium resources by over 50 years: Govt  • Australia 'excited to play' at inaugural Kho Kho World Cup   • Indian startup ecosystem raises over Rs 29,200 crore in 2024, witnesses record 13 IPOs  • K’taka govt employee digitally arrested for six hours, robbed of Rs 19 lakh 
Last updated: 27 Sep, 2014  

CPhI Conferences Launches Vaccines Summit 2012

PR Newswire | 11 Jul, 2012
CPhI Conferences Launches Vaccines Summit 2012

MUMBAI, India: While the Indian pharmaceutical industry is expecting only a single digit growth rate in the near future, and is predicted to reach US$975 billion by 2013, the outlook of the vaccine industry is one of continued growth. Between 2009  and 2010, the global vaccine market grew almost 15% to US$25.3 billion, and is predicted to reach US$56.7 billion by 2017.

In this regard, CPhI Conferences announces its inaugural two-day strategic Vaccines Summit 2012, taking place from August 30-31 in Hyderabad, India. This conference focuses on the latest R&D advancements in vaccines for tuberculosis vaccines, pneumococcal conjugate vaccines, HPV vaccines, combination vaccines, dengue vaccines, AIDS, malaria and thermostable vaccines and novel adjuvants. It also focuses on the vital concerns around vaccine manufacturing, scale up, QbD, cold chain management and technology transfer.

The event includes an exclusive seminar covering global regulations for vaccines, taking place on 29 August 2012, which features the recent government initiatives, WHO prequalification for vaccines, regulatory framework for India and best ways of overcoming regulatory complexities in the Emerging Markets (EMs) and Rest of the World (RoW) countries. This regulatory focused day is led by experts including Nirmal Kumar Ganguly, Distinguished Biotechnology Research Professor, Department of Biotechnology (Former Director General, Indian Council of Medical Research), Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Department of Biotechnology, Ministry of Science and Technology, Ajay Khera, Public Health Consultant and Deputy Commissioner, Child Health and Immunisation, Ministry of Health and Family Welfare, Madhur Gupta, Technical Officer (Pharmaceuticals), WHO India.

Visit http://www.vaccines-summit.com/pr to view the complete programme.

CPhI Conferences is a UBM brand. UBM (LSE: UBM) organises more than 300 events in 21 countries across industry sectors including food, pharma, energy, property, aviation, telecom and more. Our expertise is a proven guarantee of the quality of our events.

UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit the UBM India website, http://www.ubmindia.in.

For further information please contact:
Ms Asan Bano
Customer Services Executive
CPhI Conferences
+91(022)4046-1466
conferences-india@ubm.com

SOURCE CPhI Conferences India

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Will the new MSME credit assessment model simplify financing?
 Yes
 No
 Can't say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter